Effectiveness of tenapanor for treating hyperphosphatemia in patients receiving dialysis: a plain language summary of the OPTIMIZE study.
| Autor: | Sprague SM; Endeavor Health/NorthShore University HealthSystem, Evanston, IL, USA.; University of Chicago Pritzker School of Medicine, Chicago, IL, USA., Edelstein S; Ardelyx, Inc., Waltham, MA, USA., Spiegel DM; Ardelyx, Inc., Waltham, MA, USA., Rosenbaum DP; Ardelyx, Inc., Waltham, MA, USA., Thomas C; Patient author, Renal Support Network, Glendale, CA, USA., Weiner DE; Tufts Medical Center, Boston, MA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Current medical research and opinion [Curr Med Res Opin] 2024 Aug; Vol. 40 (8), pp. 1335-1343. Date of Electronic Publication: 2024 Jul 23. |
| DOI: | 10.1080/03007995.2024.2364815 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|